Lazich Ivana, Chang Anthony, Watson Sydeaka, Dhar Promila, Madhurapantula Rama S, Hammes Mary
Department of Medicine, Section of Nephrology, University of Chicago, Chicago, Illinois, USA.
Department of Pathology, University of Chicago, Chicago, Illinois, USA.
Hemodial Int. 2015 Oct;19(4):490-8. doi: 10.1111/hdi.12289. Epub 2015 Mar 2.
Diabetic patients with end-stage renal failure have higher rates of arteriovenous failures when compared with nondiabetics. The aim was to compare differences in indicators of vascular remodeling and endothelial dysfunction in veins of patients with or without diabetes at the time of surgical placement. In this prospective observational trial, vein samples were collected from patients when a brachiocephalic fistula was created. Morphometric measurements and extent of fibrosis were determined using Image J software. Histological analysis, for the presence of myofibroblasts and level of endothelial nitric oxide synthase, was performed by immunohistochemical staining and scored in semi-quantitative manner. Asymmetric dimethylarginine was determined at the time of access placement. Comparison of diabetics and nondiabetics was performed using Wilcoxon rank sum and Fisher's exact tests. Eighteen patients were included; 10 were diabetics. There was a significant difference in the measurement of vein area between groups, with diabetic vein samples having larger luminal area of average 832,001.18 μm(2) (317,582.17-3,695,670.36, P = 0.04). The maximal intimal to medial thickness ratio was higher in diabetic vein samples (0.71 vs. 0.24, P = 0.03) along with statistically significant higher maximal intimal thickness (312.12 vs. 115.14 μm, P = 0.03). There is a significant difference in vascular wall remodeling between diabetics and nondiabetics at the level of the cephalic vein at the time of brachiocephalic placement. The unexpected finding of significantly larger luminal area in diabetic veins could be a major factor positively affecting brachiocephalic outcomes in otherwise impaired remodeling in this patient population.
与非糖尿病患者相比,终末期肾衰竭的糖尿病患者动静脉内瘘失败率更高。目的是比较手术置管时糖尿病患者与非糖尿病患者静脉血管重塑指标和内皮功能障碍的差异。在这项前瞻性观察试验中,当创建头臂动静脉内瘘时从患者身上采集静脉样本。使用Image J软件确定形态测量和纤维化程度。通过免疫组织化学染色进行组织学分析,检测肌成纤维细胞的存在情况和内皮型一氧化氮合酶水平,并进行半定量评分。在置管时测定不对称二甲基精氨酸。使用Wilcoxon秩和检验和Fisher精确检验对糖尿病患者和非糖尿病患者进行比较。纳入了18名患者,其中10名是糖尿病患者。两组之间静脉面积测量存在显著差异,糖尿病患者的静脉样本管腔面积更大,平均为832,001.18μm²(317,582.17 - 3,695,670.36,P = 0.04)。糖尿病患者静脉样本的最大内膜与中膜厚度比更高(0.71对0.24,P = 0.03),同时最大内膜厚度在统计学上也显著更高(312.12对115.14μm,P = 0.03)。在头臂动静脉内瘘置管时,糖尿病患者和非糖尿病患者在头静脉水平的血管壁重塑存在显著差异。糖尿病患者静脉管腔面积显著更大这一意外发现可能是对该患者群体中原本受损的重塑过程产生积极影响的头臂动静脉内瘘结局的一个主要因素。